- Home
- MPX vs ZBIO Comparison
MPX vs ZBIO Comparison
Compare MPX & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- ZBIO
- Stock Information
- Founded
- MPX 1965
- ZBIO 2019
- Country
- MPX United States
- ZBIO United States
- Employees
- MPX N/A
- ZBIO N/A
- Industry
- MPX Marine Transportation
- ZBIO
- Sector
- MPX Industrials
- ZBIO
- Exchange
- MPX Nasdaq
- ZBIO NYSE
- Market Cap
- MPX 326.0M
- ZBIO 389.2M
- IPO Year
- MPX N/A
- ZBIO 2024
- Fundamental
- Price
- MPX $8.70
- ZBIO $9.81
- Analyst Decision
- MPX Hold
- ZBIO Strong Buy
- Analyst Count
- MPX 1
- ZBIO 7
- Target Price
- MPX $8.00
- ZBIO $32.29
- AVG Volume (30 Days)
- MPX 29.0K
- ZBIO 260.1K
- Earning Date
- MPX 04-24-2025
- ZBIO 05-16-2025
- Dividend Yield
- MPX 6.40%
- ZBIO N/A
- EPS Growth
- MPX N/A
- ZBIO N/A
- EPS
- MPX 0.50
- ZBIO N/A
- Revenue
- MPX $236,555,000.00
- ZBIO $5,000,000.00
- Revenue This Year
- MPX $3.97
- ZBIO N/A
- Revenue Next Year
- MPX $13.02
- ZBIO N/A
- P/E Ratio
- MPX $16.80
- ZBIO N/A
- Revenue Growth
- MPX N/A
- ZBIO N/A
- 52 Week Low
- MPX $7.49
- ZBIO $5.83
- 52 Week High
- MPX $12.47
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- MPX 58.49
- ZBIO N/A
- Support Level
- MPX $7.91
- ZBIO N/A
- Resistance Level
- MPX $8.35
- ZBIO N/A
- Average True Range (ATR)
- MPX 0.43
- ZBIO 0.00
- MACD
- MPX 0.07
- ZBIO 0.00
- Stochastic Oscillator
- MPX 91.90
- ZBIO 0.00
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.